AZoLifeSciences on MSN23m
Single-Cell Analysis Reveals Critical Kidney Cell Types Involved in Disease
Researchers at the University of Pennsylvania's Perelman School of Medicine have published a new study in the journal Science ...
Travere takes rare disease kidney drug to FDA despite failed trial
Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.
Bernstein raises Novo Nordisk stock target to DKK620
Bernstein analysts led by Florent Cespedes increased their price target on Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) stock to DKK620.00, up from DKK600.00, while maintaining a Market Perform rating.
Genetic map identifies 1,000 potential kidney disease treatment targets
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
GLP-1 medications show promise in slowing kidney disease progression
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...